Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement
Giovanna Mantovani(University of Milan), Agnès Linglart(Assistance Publique – Hôpitaux de Paris), Beatriz Lecumberri(Hospital Universitario La Paz), Outi Makiti, Elvire Le Norcy(Délégation Paris 5), Olaf Hiort(University of Lübeck), Eileen M. Shore(Fisher & Paykel Healthcare (New Zealand)), Murat Bastepe(Brigham and Women's Hospital), Thomas Eggermann(RWTH Aachen University), Robert J. Pignolo(Mayo Clinic in Arizona), Arrate Pereda(Hospital Universitario Araba), Guiomar Pérez de Nanclares(Hospital Universitario Araba), Regina Matsunaga Martin(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), Emily L. Germain‐Lee(University of Connecticut), Rebecca Rodado, Caroline Silve(Inserm), Lionel Groussin(Université Paris Cité), Gabriel Ángel Martos‐Moreno(Instituto de Salud Carlos III), Francesca Marta Elli(University of Milan), Michael A. Levine(Children's Hospital of Philadelphia), Faisal Ahmed(University of Glasgow), Harald Jüppner(Harvard University), Kathleen Freson(KU Leuven), Sanctis Luisa de(Department of Public Health), Lars Rejnmark(Aarhus University Hospital), M. Carola Zillikens(Erasmus MC), Roberto Bufo(Associazione Italiana Ematologia Oncologia Pediatrica), Vrinda Saraff(Birmingham Women's Hospital), Alessia Usardi(Assistance Publique – Hôpitaux de Paris), Aurora García Ramirez, Serap Turan(Marmara University), Timothée Choplin, Anya Rothenbühler(Assistance Publique – Hôpitaux de Paris), Patrick Hanna(Université Paris-Sud), Peter Kamenický(Inserm), Neveen A. T. Hamdy(Leiden University Medical Center), Masanori Minagawa(Chiba Hospital), David Monk(University of East Anglia), Philip R. Woods(The Patients Association), Marie‐Laure Kottler(Normandie Université), Susanne Thiele(University of Lübeck), Guillemette Devernois, Nina Knight(The Patients Association), Ashley H. Shoemaker(Vanderbilt University Medical Center)
Cited by 0
Related Papers
Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease
|EBioMedicine|2019|1.3k
Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase
|Proceedings of the National Academy of Sciences|2004|745
Clinical and molecular diagnosis, screening and management of Beckwith–Wiedemann syndrome: an international consensus statement
|Nature Reviews Endocrinology|2018|596